Logo-bi
Bioimpacts. 2024;14(4): 29951. doi: 10.34172/bi.2023.29951

Original Article

Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines

Chaithra R Shetty 1 ORCID, C. S. Shastry 2 * ORCID, Parasuraman P 3, Srinivas Hebbar 4

Cited by CrossRef: 0